Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma.

Yi JH, Lee GW, Do YR, Jung HR, Hong JY, Yoon DH, Suh C, Choi YS, Yi SY, Sohn BS, Kim BS, Oh SY, Park J, Jo JC, Lee SS, Oh YH, Kim SJ, Kim WS.

Ann Hematol. 2019 Sep 6. doi: 10.1007/s00277-019-03791-y. [Epub ahead of print]

PMID:
31493002
2.

Efficacy of a Decision Aid Consisting of a Video and Booklet on Advance Care Planning for Advanced Cancer Patients: Randomized Controlled Trial.

Yun YH, Kang E, Park S, Koh SJ, Oh HS, Keam B, Do YR, Chang WJ, Jeong HS, Nam EM, Jung KH, Kim HR, Choo J, Lee J, Sim JA.

J Pain Symptom Manage. 2019 Aug 20. pii: S0885-3924(19)30450-6. doi: 10.1016/j.jpainsymman.2019.07.032. [Epub ahead of print]

PMID:
31442484
3.

Stable and Colorful Perovskite Solar Cells Using a Nonperiodic SiO2/TiO2 Multi-Nanolayer Filter.

Yoo GY, Azmi R, Kim C, Kim W, Min BK, Jang SY, Do YR.

ACS Nano. 2019 Aug 20. doi: 10.1021/acsnano.9b03098. [Epub ahead of print]

PMID:
31382733
4.

Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System.

Jung KS, Kim YJ, Kim YK, Park SK, Kim HG, Kim SJ, Park J, Choi CW, Do YR, Kim I, Park S, Mun YC, Jeong SH, Kim MK, Yi HG, Chang MH, Kim SY, Lee JH, Jang JH.

Clin Lymphoma Myeloma Leuk. 2019 Jun 27. pii: S2152-2650(19)30234-4. doi: 10.1016/j.clml.2019.06.003. [Epub ahead of print]

PMID:
31375393
5.

Correction to: Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey.

Yun YH, Kim KN, Sim JA, Kang E, Lee J, Choo J, Yoo SH, Kim M, Kim YA, Kang BD, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Maeng CH, Kang EJ, Do YR, Choi YS, Jung KH.

Support Care Cancer. 2019 Oct;27(10):3921-3926. doi: 10.1007/s00520-019-04985-w.

PMID:
31309297
6.

Dual wavelength lasing of InGaN/GaN axial-heterostructure nanorod lasers.

Chun SY, Yoo GY, Jeong S, Park SM, Eo YJ, Kim W, Do YR, Song JK.

Nanoscale. 2019 Aug 1;11(30):14186-14193. doi: 10.1039/c9nr03906f.

PMID:
31267116
7.

A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial).

Park BB, Kim WS, Suh C, Hong JY, Yang DH, Lee WS, Do YR, Koh YI, Won JH, Kim MK, Jo JC, Hyun SY, Kim JA, Oh YH, Lee SS.

Leuk Lymphoma. 2019 Jun 6:1-7. doi: 10.1080/10428194.2019.1622100. [Epub ahead of print]

PMID:
31170847
8.

Stable and Efficient Green Perovskite Nanocrystal-Polysilazane Films for White LEDs Using an Electrospray Deposition Process.

Yoon HC, Do YR.

ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22510-22520. doi: 10.1021/acsami.9b04164. Epub 2019 Jun 11.

PMID:
31144799
9.

The effects of erythropoiesis-stimulating agents on the management of chemotherapy-induced anemia and tumor growth in diffuse large B-cell lymphoma patients.

Park LC, Song YJ, Kim DJ, Kim MJ, Jo JC, Lee WS, Shin HJ, Oh SY, Do YR, Jeong JY, Lee HS; Consortium for Improving Survival of Lymphoma (CISL).

Int J Cancer. 2019 Nov 1;145(9):2459-2467. doi: 10.1002/ijc.32328. Epub 2019 May 6.

PMID:
30973963
10.

RGB-Colored Cu(In,Ga)(S,Se)2 Thin-Film Solar Cells with Minimal Efficiency Loss Using Narrow-Bandwidth Stopband Nano-Multilayered Filters.

Lee S, Yoo GY, Kim B, Kim MK, Kim C, Park SY, Yoon HC, Kim W, Min BK, Do YR.

ACS Appl Mater Interfaces. 2019 Mar 13;11(10):9994-10003. doi: 10.1021/acsami.8b21853. Epub 2019 Feb 27.

PMID:
30773871
11.

Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma.

Park S, Jo JC, Do YR, Yang DH, Lim SN, Lee WS, Kim WS, Lee HS, Hong DS, Kim HJ, Shin HJ.

Clin Lymphoma Myeloma Leuk. 2019 Mar;19(3):149-156. doi: 10.1016/j.clml.2018.11.003. Epub 2018 Nov 12.

PMID:
30581162
12.

The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.

Lee GW, Park SW, Go SI, Kim HG, Kim MK, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Kim H, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Yi HG, Moon JH, Choi CW, Kim SH, Kim BS, Park MR, Shim H, Song MK, Kim Y, Kim K.

Acta Haematol. 2018;140(3):146-156. doi: 10.1159/000490488. Epub 2018 Sep 25.

PMID:
30253397
13.

Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.

Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, Lee JH, Kang DY, Lee WS, Lee SM, Do YR, Ham JS, Kim SJ, Kim WS, Choi JY, Yang DH, Kwak JY.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2482-2483. doi: 10.1007/s00259-018-4163-4.

PMID:
30221329
15.

Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia.

Kim H, Kim S, Kim HJ, Kim YK, Kwak JY, Yhim HY, Kim SH, Do YR, Oh S, Lee SE, Jootar S, Cui JW, Kim DW.

Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e391-e399. doi: 10.1016/j.clml.2018.06.031. Epub 2018 Jul 4.

16.

A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.

Yhim HY, Park Y, Han YH, Kim S, Kang SR, Moon JH, Jeong JH, Shin HJ, Kim K, Choi YS, Kim K, Kim MK, Kong E, Kim DS, Eo JS, Lee JH, Kang DY, Lee WS, Lee SM, Do YR, Ham JS, Kim SJ, Kim WS, Choi JY, Yang DH, Kwak JY.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2274-2284. doi: 10.1007/s00259-018-4093-1. Epub 2018 Jul 28. Erratum in: Eur J Nucl Med Mol Imaging. 2018 Sep 17;:.

PMID:
30056546
17.

Low-Yellowing Phosphor-in-Glass for High-Power Chip-on-board White LEDs by Optimizing a Low-Melting Sn-P-F-O Glass Matrix.

Yoon HC, Yoshihiro K, Yoo H, Lee SW, Oh JH, Do YR.

Sci Rep. 2018 May 9;8(1):7412. doi: 10.1038/s41598-018-25680-6.

18.

Priorities of a "good death" according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey.

Yun YH, Kim KN, Sim JA, Kang E, Lee J, Choo J, Yoo SH, Kim M, Kim YA, Kang BD, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Maeng CH, Kang EJ, Do YR, Choi YS, Jung KH.

Support Care Cancer. 2018 Oct;26(10):3479-3488. doi: 10.1007/s00520-018-4209-y. Epub 2018 Apr 22. Erratum in: Support Care Cancer. 2019 Jul 16;:.

PMID:
29682690
19.

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis.

Hong JY, Yoon DH, Suh C, Kim WS, Kim SJ, Jo JC, Kim JS, Lee WS, Oh SY, Park Y, Kim SY, Lee MH, Lee HS, Do YR.

Ann Hematol. 2018 Aug;97(8):1437-1443. doi: 10.1007/s00277-018-3317-6. Epub 2018 Apr 4.

PMID:
29619501
20.

Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia.

Noh H, Jung SY, Kwak JY, Kim SH, Oh SJ, Zang DY, Lee S, Park HL, Jo DJ, Shin JS, Do YR, Kim DW, Lee JI.

Cancer Med. 2018 May;7(5):1766-1773. doi: 10.1002/cam4.1436. Epub 2018 Mar 25.

21.

A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea.

Shin J, Koh Y, Yoon SH, Cho JY, Kim DY, Lee KH, Kim HJ, Ahn JS, Kim YK, Park J, Sohn SK, Moon JH, Lee YJ, Yoon S, Lee JO, Cheong JW, Kim KH, Kim SH, Kim HG, Kim H, Nam SH, Do YR, Park SG, Park SK, Bae SH, Song HH, Shin DY, Oh D, Kim MK, Jung CW, Park S, Kim I.

Cancer Med. 2018 May;7(5):1814-1823. doi: 10.1002/cam4.1450. Epub 2018 Mar 25.

22.

Attitudes toward early palliative care in cancer patients and caregivers: a Korean nationwide survey.

Yoo SH, Kim M, Yun YH, Keam B, Kim YA, Kim YJ, Shim HJ, Song EK, Kang JH, Kwon JH, Lee JL, Lee SN, Kim SY, Kang EJ, Do YR, Choi YS, Jung KH.

Cancer Med. 2018 May;7(5):1784-1793. doi: 10.1002/cam4.1441. Epub 2018 Mar 25.

23.

Efficient and Stable CsPbBr3 Quantum-Dot Powders Passivated and Encapsulated with a Mixed Silicon Nitride and Silicon Oxide Inorganic Polymer Matrix.

Yoon HC, Lee S, Song JK, Yang H, Do YR.

ACS Appl Mater Interfaces. 2018 Apr 11;10(14):11756-11767. doi: 10.1021/acsami.8b01014. Epub 2018 Mar 30.

PMID:
29566326
24.

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma.

Hong J, Kim SJ, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, Kwon JH, Kong JH, Oh SY, Lee S, Bae SH, Yang DH, Jun HJ, Lee HS, Yun HJ, Lee SI, Kim MK, Yi JH, Lee JH, Kim WS, Suh C.

Oncotarget. 2017 Sep 18;8(54):92171-92182. doi: 10.18632/oncotarget.20988. eCollection 2017 Nov 3.

25.

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.

Kwong YL, Kim SJ, Tse E, Oh SY, Kwak JY, Eom HS, Do YR, Mun YC, Lee SR, Shin HJ, Suh C, Chuang SS, Lee YS, Lim ST, Izutsu K, Suzuki R, Relander T, d'Amore F, Schmitz N, Jaccard A, Kim WS.

Ann Oncol. 2018 Jan 1;29(1):256-263. doi: 10.1093/annonc/mdx684.

PMID:
29077846
26.

Enhanced DC-Operated Electroluminescence of Forwardly Aligned   p/MQW/n InGaN Nanorod LEDs via DC Offset-AC Dielectrophoresis.

Eo YJ, Yoo GY, Kang H, Lee YK, Kim CS, Oh JH, Lee KN, Kim W, Do YR.

ACS Appl Mater Interfaces. 2017 Nov 1;9(43):37912-37920. doi: 10.1021/acsami.7b09794. Epub 2017 Oct 19.

PMID:
29019239
27.

Phase III Clinical Trial (RERISE study) Results of Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia.

Kwak JY, Kim SH, Oh SJ, Zang DY, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Choi CW, Lee WS, Mun YC, Kong JH, Chung JS, Shin HJ, Kim DY, Park J, Jung CW, Bunworasate U, Comia NS, Jootar S, Reksodiputro AH, Caguioa PB, Lee SE, Kim DW.

Clin Cancer Res. 2017 Dec 1;23(23):7180-7188. doi: 10.1158/1078-0432.CCR-17-0957. Epub 2017 Sep 22.

28.

Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.

Cho H, Yoon DH, Lee JB, Kim SY, Moon JH, Do YR, Lee JH, Park Y, Lee HS, Eom HS, Shin HJ, Min CK, Kim JS, Jo JC, Kang HJ, Mun YC, Lee WS, Lee JJ, Suh C, Kim K; and the Korean Multiple Myeloma Working Party.

Am J Hematol. 2017 Dec;92(12):1280-1286. doi: 10.1002/ajh.24891. Epub 2017 Sep 8.

29.

Origin of highly efficient photoluminescence in AgIn5S8 nanoparticles.

Han NS, Yoon HC, Jeong S, Oh JH, Park SM, Do YR, Song JK.

Nanoscale. 2017 Jul 27;9(29):10285-10291. doi: 10.1039/c7nr02380d.

PMID:
28696455
30.

Circadian-tunable Perovskite Quantum Dot-based Down-Converted Multi-Package White LED with a Color Fidelity Index over 90.

Yoon HC, Oh JH, Lee S, Park JB, Do YR.

Sci Rep. 2017 Jun 5;7(1):2808. doi: 10.1038/s41598-017-03063-7.

31.

Identification of a novel PML-RARG fusion in acute promyelocytic leukemia.

Ha JS, Do YR, Ki CS, Lee C, Kim DH, Lee W, Ryoo NH, Jeon DS.

Leukemia. 2017 Sep;31(9):1992-1995. doi: 10.1038/leu.2017.167. Epub 2017 May 30. No abstract available.

PMID:
28555082
32.

Multiple-Color-Generating Cu(In,Ga)(S,Se)2 Thin-Film Solar Cells via Dichroic Film Incorporation for Power-Generating Window Applications.

Yoo GY, Jeong JS, Lee S, Lee Y, Yoon HC, Chu VB, Park GS, Hwang YJ, Kim W, Min BK, Do YR.

ACS Appl Mater Interfaces. 2017 May 3;9(17):14817-14826. doi: 10.1021/acsami.7b01416. Epub 2017 Apr 20.

PMID:
28406026
33.

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma.

Kim MK, Kim K, Min CK, Kwak JY, Bae SB, Yoon SS, Lee JJ, Kim KH, Nam SH, Mun YC, Kim HJ, Bae SH, Shin HJ, Lee JH, Park JS, Jeong SH, Lee MH, Kim YS, Lee HS, Park KW, Lee WS, Lee SM, Lee JO, Hyun MS, Jo DY, Lim SN, Lee JH, Cho DY, Do YR, Kim JA, Park SK, Kim JS, Kim SJ, Kim H, Yi HG, Moon JH, Choi CW, Kim SH, Joo YD, Kim HG, Kim BS, Park MR, Song MK, Kim SY.

Oncotarget. 2017 Jun 6;8(23):37605-37618. doi: 10.18632/oncotarget.16790.

34.

Multicenter Phase II Clinical Trial of Genexol-PM® with Gemcitabine in Advanced Biliary Tract Cancer.

Kim JY, Do YR, Song HS, Cho YY, Ryoo HM, Bae SH, Kim JG, Chae YS, Kang BW, Baek JH, Kim MK, Lee KH, Park K.

Anticancer Res. 2017 Mar;37(3):1467-1473.

PMID:
28314319
35.

Sequential strategy for umbilical cord blood transplantation in a Korean Fanconi anemia girl with refractory acute myelomonocytic leukemia and complex karyotype.

Shim YJ, Kim HS, Do YR, Ha JS, Yabe H.

Pediatr Transplant. 2017 Mar;21(2). doi: 10.1111/petr.12871. Epub 2016 Dec 15. No abstract available.

PMID:
27976485
36.

Cycles of circadian illuminance are sufficient to entrain and maintain circadian locomotor rhythms in Drosophila.

Cho E, Oh JH, Lee E, Do YR, Kim EY.

Sci Rep. 2016 Nov 24;6:37784. doi: 10.1038/srep37784.

37.

Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study.

Kim SJ, Hong JS, Chang MH, Kim JA, Kwak JY, Kim JS, Yoon DH, Lee WS, Do YR, Kang HJ, Eom HS, Park Y, Won JH, Mun YC, Kim HJ, Kwon JH, Kong JH, Oh SY, Lee S, Bae SH, Yang DH, Jun HJ, Kim YS, Yun HJ, Lee SI, Kim MK, Park EK, Kim WS, Suh C.

Oncotarget. 2016 Nov 1;7(44):72033-72043. doi: 10.18632/oncotarget.12459.

38.

Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma.

Moon JH, Lee BH, Kim JA, Lee YJ, Chae YS, Yhim HY, Kwak JY, Do YR, Park Y, Song MK, Shin HJ, Kim T, Lee JJ, Yang DH.

Leuk Res. 2016 Oct;49:80-7. doi: 10.1016/j.leukres.2016.08.015. Epub 2016 Aug 31.

PMID:
27608179
39.

High-efficiency red electroluminescent device based on multishelled InP quantum dots.

Jo JH, Kim JH, Lee KH, Han CY, Jang EP, Do YR, Yang H.

Opt Lett. 2016 Sep 1;41(17):3984-7. doi: 10.1364/OL.41.003984.

PMID:
27607953
40.

Study of Perovskite QD Down-Converted LEDs and Six-Color White LEDs for Future Displays with Excellent Color Performance.

Yoon HC, Kang H, Lee S, Oh JH, Yang H, Do YR.

ACS Appl Mater Interfaces. 2016 Jul 20;8(28):18189-200. doi: 10.1021/acsami.6b05468. Epub 2016 Jul 7.

PMID:
27349270
41.

Horizontally assembled green InGaN nanorod LEDs: scalable polarized surface emitting LEDs using electric-field assisted assembly.

Park HK, Yoon SW, Eo YJ, Chung WW, Yoo GY, Oh JH, Lee KN, Kim W, Do YR.

Sci Rep. 2016 Jun 21;6:28312. doi: 10.1038/srep28312.

42.

Tunable White Fluorescent Copper Gallium Sulfide Quantum Dots Enabled by Mn Doping.

Jo DY, Kim D, Kim JH, Chae H, Seo HJ, Do YR, Yang H.

ACS Appl Mater Interfaces. 2016 May 18;8(19):12291-7. doi: 10.1021/acsami.6b01763. Epub 2016 May 5.

PMID:
27120773
43.

The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea.

Lee HS, Min CK, Lee JJ, Kim K, Kim SJ, Yoon DH, Eom HS, Lee H, Lee WS, Shin HJ, Lee JH, Park Y, Jo JC, Do YR, Mun YC, Lee MH; Korean Multiple Myeloma Working Party (KMMWP).

Ann Hematol. 2016 May;95(6):911-9. doi: 10.1007/s00277-016-2660-8. Epub 2016 Apr 6.

PMID:
27052989
44.

Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation.

Kong BS, Im SJ, Lee YJ, Cho YH, Do YR, Byun JW, Ku CR, Lee EJ.

PLoS One. 2016 Mar 22;11(3):e0149394. doi: 10.1371/journal.pone.0149394. eCollection 2016.

45.

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study.

Lee SE, Choi SY, Song HY, Kim SH, Choi MY, Park JS, Kim HJ, Kim SH, Zang DY, Oh S, Kim H, Do YR, Kwak JY, Kim JA, Kim DY, Mun YC, Lee WS, Chang MH, Park J, Kwon JH, Kim DW.

Haematologica. 2016 Jun;101(6):717-23. doi: 10.3324/haematol.2015.139899. Epub 2016 Feb 17.

46.

A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas.

Kim SJ, Shin DY, Kim JS, Yoon DH, Lee WS, Lee H, Do YR, Kang HJ, Eom HS, Ko YH, Lee SH, Yoo HY, Hong M, Suh C, Kim WS.

Ann Oncol. 2016 Apr;27(4):712-8. doi: 10.1093/annonc/mdv624. Epub 2016 Feb 8.

PMID:
26861608
47.

Clinical Features and Survival of Patients With Follicular Lymphoma in Korea.

Cho SH, Suh C, Do YR, Lee JJ, Yun HJ, Oh SY, Lee HS, Cho SG, Cho IS, Lee WS, Won YW, Kim HJ, Lee HG, Lee SI, Lim SN, Sohn BS, Ahn HJ, Chang MH, Kwon KA, Kim WS.

Clin Lymphoma Myeloma Leuk. 2016 Apr;16(4):197-202. doi: 10.1016/j.clml.2015.12.012. Epub 2016 Jan 6.

PMID:
26850215
48.

Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study.

Kim JS, Yoon DH, Park S, Yoon SS, Cho SG, Min CK, Lee JJ, Yang DH, Kwak JY, Eom HS, Kim WS, Kim H, Do YR, Moon JH, Lee J, Suh C.

Ann Hematol. 2016 Mar;95(4):603-11. doi: 10.1007/s00277-016-2589-y. Epub 2016 Jan 11.

PMID:
26754633
49.

A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome.

Jeong SH, Kim YJ, Lee JH, Kim YK, Kim SJ, Park SK, Do YR, Kim I, Mun YC, Kim HG, Lee WS, Yi HG, Joo YD, Choi CW, Kim SR, Na SM, Jang JH.

Oncotarget. 2015 Dec 29;6(42):44985-94. doi: 10.18632/oncotarget.6242.

50.

Improved performance of dye-sensitized solar cells using dual-function TiO(2) nanowire photoelectrode.

Akbar ZA, Oh JH, Hadmojo WT, Yang SJ, Do YR, Jang SY.

Opt Express. 2015 Sep 21;23(19):A1280-7. doi: 10.1364/OE.23.0A1280.

PMID:
26406757

Supplemental Content

Support Center